Personalized Neoantigen Peptide Vaccines for Solid Tumors

Clinical trial NCT07002203 · RECRUITING

Trial details

NCT number: NCT07002203
Sponsor: Seqker Biosciences, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors Advanced Cancer Recurrent Cancer Neoantigen-Specific Immunotherapy Personalized Cancer Vaccine

Start date: 2024-03-01
Primary completion: 2027-08-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.